NHI.no
Annonse
Informasjon

Krokfinger, Dupuytrens kontraktur

Dette er en fortykkelse av bindevevshinnen i håndflaten. Over tid kan det føre til at en eller flere fingre blir krokete, og det blir umulig å strekke ut disse fingrene.

Krokfinger forekommer hyppigere blant folk fra Norden enn fra andre deler av verden.

Sist oppdatert:

7. feb. 2022

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Dupuytrens kontraktur . Referanselisten for dette dokumentet vises nedenfor

  1. Trojian TH, Chu SM. Dupuytrens disease: diagnosis and treatment. Am Fam Physician 2007; 76: 86-9. PubMed
  2. Jemec B. Dupuytrens kontraktur. Ugeskr Læger 2003; 165: 1863-5. PubMed
  3. Townley WA, Baker R, Sheppard N, Grobbelaar O. Dupuytren's contracture unfolded. BMJ 2006; 332: 397-400. PubMed
  4. Gudmundsson KG, Arngrímsson R, Sigfússon N et al. Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik Study. J Clin Epidemiol. 2000 Mar 1;53(3):291-6. doi: 10.1016/s0895-4356(99)00145-6. PMID: 10760640. PubMed
  5. Ruettermann M, Hermann RM, Khatib-Chahidi K, et al. Morbus Dupuytren – Ätiologie und Behandlung. Dtsch Arztebl Int 2021; 118: 781-8. PubMed
  6. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J 2005; 81: 425-8. PubMed
  7. Gudmundsson KG, Arngrímsson R, Sigfússon N et al. Epidemiology of Dupuytren's disease. The Reykavik Study. J Clin Epid 2000;53:291-6. PubMed
  8. Gudmundsson KG, Arngrimsson R, Jonsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease. Scand J Rheumatol 2001; 30: 31-4. PubMed
  9. Shih B, Bayat A. Scientific understanding and clinical management of Dupuytren disease. Nat Rev Rheumatol 2010; 6:715. PubMed
  10. Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg Br 2003; 28: 351-6. PubMed
  11. Aggarwal R, Blazar PE. Dupuytren's contracture. UpToDate, last updated Dec 14, 2021. www.uptodate.com
  12. Godtfredsen NS, Lucht H, Prescott E, Sorensen TI, Gronbaek M. A prospective study linked both alcohol and tobacco to Dupuytren's disease. J Clin Epidemiol 2004; 57: 858-63. PubMed
  13. Geoghegan JM, Forbes J, Clark DI, Smith C, Hubbard R. Dupuytren's disease risk factors. J Hand Surg Br 2004; 29: 423-6. PubMed
  14. Liss GM, Stock SR. Can Dupuytren's contracture be work-related?: review of the evidence. Am J Ind Med 1996; 29: 521. PubMed
  15. webpage Medline Plus medlineplus.gov
  16. Lanting R, van den Heuvel ER, Werker PM. Clusters in Short-term Disease Course in Participants With Primary Dupuytren Disease. J Hand Surg Am. 2016 Mar. 41 (3):354-61.
  17. Martina Hansens Hospital, Title: Dupuytrens kontraktur, operasjon, cited 05.03.2024 www.martinahansen.no
  18. Knobloch K, Hellweg M, Sorg H et al. Focused electromagnetic high-energetic extracorporeal shockwave (ESWT) reduces pain levels in the nodular state of Dupuytren's disease-a randomized controlled trial (DupuyShock). Lasers Med Sci. 2022 Feb;37(1):323-333. doi: 10.1007/s10103-021-03254-9. Epub 2021 Jan 23. PMID: 33483776; PMCID: PMC8803781
  19. Trojian TH, Rodner CM. Dupuytren's contracture. BMJ Best Practice, last reviewed 7 Jan 2022. bestpractice.bmj.com
  20. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren's disease with triamcinolone acetonide. J Hand Surg Am. 2000 Nov;25(6):1157-62. doi: 10.1053/jhsu.2000.18493. PMID: 11119679.
  21. Räisänen MP, Leppänen OV, Soikkeli J et. al Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture : A Randomized Controlled Trial. Ann Intern Med. 2024 Feb 13. doi: 10.7326/M23-1485. Epub ahead of print. PMID: 38346307 PubMed
  22. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am 2007; 32: 767 PubMed
  23. Gaston RG, MD, Larsen SE, Pess GM, et al. The efficacy and safety of concurrent collagenase Clostridium histolyticum injections for 2 Dupuytren contractures in the same hand: a prospective, multicenter study. J Hand Surg Am. 2015 Oct;40(10):1963-71 . pmid:26216077 PubMed
  24. Odinsson A, Brenne LE, Lurie TB, Finsen V. Dupuytren’s contracture. The safety and efficacy of collagenase treatment. J Hand Surg Asian Pac Vol. 2016 Jun;21(2):187-92. . pmid:27454632 PubMed
  25. Peimer CA, Blazar P, Coleman S, et al. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study): 5-Year Data.. J Hand Surg Am. 2015 Aug;40(8):1597-605 . pmid:26096221 PubMed
  26. van Rijssen AL, Gerbrandy FS, Ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am. 2006;31:717-725. PubMed
  27. Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg Am 2005; 30: 1021-5. PubMed
  28. Brazzelli M, Cruickshank M, Tassie E, et al. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. Health Technol Assess. 2015;19:1-202. PubMed
  29. Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009; 361: 968-79. New England Journal of Medicine
  30. Witthaut J, Bushmakin AG, Gerber RA, et al. Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study. Clin Drug Investig 2011; 31: 791-8. PubMed
  31. Gilpin D, Coleman S, Hall S, et al. Injectable collagenase clostridium histolyticum: A new nonsurgical treatment for Dupuytren's disease. J Hand Surg 2010; 35: 2027-38. PubMed
  32. Lanting R, van den Heuvel ER, Westerink B et al. Prevalence of Dupuytren disease in The Netherlands. Plast Reconstr Surg. 2013 Aug;132(2):394-403. doi: 10.1097/PRS.0b013e3182958a33. PMID: 23897337 PubMed
  33. Broekstra DC, Kuo RYL, Burn E et al. Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis. Plast Reconstr Surg. 2023 Mar 1;151(3):581-591. doi: 10.1097/PRS.0000000000009919. Epub 2022 Nov 22. PMID: 36730480; PMCID: PMC9944385
  34. Nordenskjöld J, Englund M, Zhou C, Atroshi I. Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study. J Hand Surg Eur Vol. 2017 Sep;42(7):673-677. doi: 10.1177/1753193416687914. Epub 2017 Jan 17. PMID: 28093015 PubMed
  35. Larsen S, Krogsgaard DG, Aagaard Larsen L, Iachina M, Skytthe A, Frederiksen H. Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish twin pairs. J Hand Surg Eur Vol. 2015 Feb;40(2):171-6. doi: 10.1177/1753193414535720. Epub 2014 May 16. PMID: 24835475; PMCID: PMC4810018
  36. Riesmeijer SA, Kamali Z, Ng M et.al genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren's disease. Nat Commun. 2024 Jan 3;15(1):199. doi: 10.1038/s41467-023-44451-0. PMID: 38172110; PMCID: PMC10764787
  37. Brunelli S, Bonanni C, Traballesi M et. al Radial extracorporeal shock wave therapy: a novel approach for the treatment of Dupuytren's contractures: A case report. Medicine (Baltimore). 2020 Jun 12;99(24):e20587. doi: 10.1097/MD.0000000000020587. PMID: 32541491; PMCID: PMC7302658
Annonse
Annonse